jab-3312
Showing 1 - 4 of 4
Solid Tumor, Adult Trial in United States (JAB-3312, Binimetinib, Pembrolizumab)
Recruiting
- Solid Tumor
- NSCLC
- JAB-3312
- +4 more
-
Phoenix, Arizona
- +14 more
Oct 26, 2022
NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in United States (JAB-3312)
Recruiting
- Non-small Cell Lung Cancer
- +6 more
- JAB-3312
-
Denver, Colorado
- +3 more
Mar 13, 2022
NSCLC, Colorectal Cancer, Pancreatic Ductal Carcinoma Trial in Beijing, Henan (JAB-3312)
Recruiting
- Non-small Cell Lung Cancer
- +6 more
- JAB-3312
-
Beijing, Beijing, China
- +4 more
Dec 28, 2021